Clinuvel Pharmaceuticals
CUV.AX
#7543
Rank
NZ$0.68 B
Marketcap
NZ$13.66
Share price
-0.51%
Change (1 day)
7.92%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: NZ$56.69 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$62.5 Million. In 2025 the company made an earning of NZ$56.69 Million, an increase over its 2024 earnings that were of NZ$56.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025NZ$56.69 M0.26%
2024NZ$56.54 M11.35%
2023NZ$50.77 M28.31%
2022NZ$39.57 M22.8%
2021NZ$32.22 M112.63%
2020NZ$15.15 M-28.73%
2019NZ$21.26 M32.79%
2018NZ$16.01 M75.41%
2017NZ$9.13 M-332.52%
2016-NZ$3.93 Million-70.68%
2015-NZ$13.4 Million53.78%
2014-NZ$8.72 Million-16.1%
2013-NZ$10.39 Million-37.92%
2012-NZ$16.73 Million-18.19%
2011-NZ$20.45 Million25.31%
2010-NZ$16.32 Million-21.53%
2009-NZ$20.8 Million-11.27%
2008-NZ$23.44 Million80.4%
2007-NZ$12.99 Million-2.46%
2006-NZ$13.32 Million-5.35%
2005-NZ$14.07 Million60.55%
2004-NZ$8.77 Million97.37%
2003-NZ$4.44 Million50.62%
2002-NZ$2.95 Million121.22%
2001-NZ$1.34 Million254.48%
2000-NZ$0.38 Million